ASCEND study of natalizumab efficacy on reducing disability in patients with secondary progressive multiple sclerosis: Baseline demographics and disease characteristics

Authors
Category Primary study
ConferenceMultiple Sclerosis
Year 2013
This article has no abstract
Epistemonikos ID: 29503946eca2c9d675930d1d1cc151906f72ad81
First added on: Apr 30, 2026